Corbevax

News Story & Video

January 5, 2022

A new COVID vaccine has been produced by the Texas Children's Hospital and Baylor College of Medicine that uses a more traditional, non-mRNA approach. The research and development began about 10 years ago for coronaviruses in general, and has been adapted to COVID-19 using a strategy similar to the one used to make existing Hepatitis B vaccines.

Human trials have already been done successfully.The low-cost vaccine is targeted for poorer, high population countries such as India, which has already authorized production of 100 million doses.

I doubt that it will be approved for use in the United States, since that would undoubtedly destroy the potential fortunes of many mRNA vaccine investors.

Overview What Doctors Say Irrationality The Virus The Vaccines Research Pandemic Origins Social Engineering Civil Liberties Site Map
General Information Vaccine Types
Posted: January 11, 2022